|
10 Aug 2020 |
Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors
|
|
10 Aug 2020 |
AnaptysBio Reports Top-Line Data From Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps
|
|
10 Aug 2020 |
Pieris and Lilly Enter Into a Clinical Trial Collaboration to Evaluate Combination of PRS-343 With Ramucirumab and Paclitaxel in Gastric Cancer
|
|
10 Aug 2020 |
Genentech Provides Update on Phase III Studies of Etrolizumab in People With Moderately to Severely Active Ulcerative Colitis
|
|
08 Aug 2020 |
FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings
|
|
08 Aug 2020 |
Opdivo® (nivolumab) Plus Yervoy® (ipilimumab) Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
|
|
08 Aug 2020 |
FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
|
|
07 Aug 2020 |
U.S. Food and Drug Administration Approves Lampit® (nifurtimox) for the Treatment of Chagas Disease in Children
|
|
07 Aug 2020 |
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan: Takeda
|
|
07 Aug 2020 |
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
|
|
07 Aug 2020 |
CStone Announces CS1001 (Anti-PD-L1 mAb) Phase III Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous Non-Small Cell Lung Cancer and Plans to Submit a New Drug Application
|
|
07 Aug 2020 |
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
|
|
07 Aug 2020 |
ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1
|
|
07 Aug 2020 |
Genentech Provides Update On Phase III Study Of Tecentriq In Combination With Paclitaxel For People With Metastatic Triple-Negative Breast Cancer
|
|
07 Aug 2020 |
Editas Medicine Regains Full Global Rights to Ocular Medicines
|
|
07 Aug 2020 |
Novavax and Serum Institute of India Announce Development and Commercial Collaboration
|
|
07 Aug 2020 |
Novartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps
|
|
06 Aug 2020 |
Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients
|
|
06 Aug 2020 |
Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
|
|
06 Aug 2020 |
Precigen Triple-Gene Provides Six-month Follow-up Data from Phase I Study of INXN-4001, a Multigenic Investigational Therapeutic Candidate for Heart Failure
|
